TCL Archive New Seer Report Says Five Year Relative Survival At 49 Per Cent Over all, 50 Per Cent For White November 30, 1984
TCL Archive Oral Capecitabine Equal To 5FU-Leucovorin In Adjuvant Stage III Colon Cancer Treatment June 25, 2004
TCL Archive NCAB Seeks Exemption From New Reimbursement Plan For Clinical Trials, Modification Of Hospice Regs February 11, 1983
TCL Archive In Brief: Trials Find DiBella Treatment Ineffective; Wistar Wins $1 Million Grant For Recruitment December 4, 1998
